"Superbug antibiotics: New drugs advance amid R&D investment shortfall"

---

By Howard Lovy -- Fierce Biotech Research

19 July 2011

"It sounds like something out of a science fiction B-movie or a Steven King novel.  Out-of-control superbugs that are resistant to anything humans can throw at them.  Unfortunately, it's no fiction.  It's deadly serious.

The problem is so serious that the World Health Organization recently warned of an impending drug-resistance crisis if humanity does not do something quickly. 

WHO Director-General Margaret Chan forecasted the approach of a "post-antibiotic era, in which many common infections will no longer have a cure and, once again, kill unabated." 

The WHO called on governments and researchers to step up funding and discovery of new medicines to take the place of antimicrobial drugs that have been rendered ineffective or useless through the evolution of drug-resistant diseases.  At the moment, there is not much to take the place of current antibiotics that are increasingly ineffective. 

Today, there are only two Big Pharma companies, GlaxoSmithKline and AstraZeneca, with active antibiotic R programs, UPI recently reported, citing the Infectious Diseases Society of America.  In 1990, there were nearly 20."


Read the full superbug antibiotics report:

http://www.fiercebiotechresearch.com/special-reports/superbug-antibiotics-new-drugs-advance-amid-rd-investment-shortfall?utm_medium=nl&utm_source=internal

&

http://www.fiercebiotechresearch.com/special-reports/superbug-antibiotics-new-drugs-advance-amid-rd-investment-shortfall/superbug-antibio

--->> & Etc.

-----------

Dateline -- San Diego, Calif.: 20 July 2011 -- 12:40 AM


Posted by:

David A. Palella
BIOSCIENCE VENTURES Inc.

San Diego, California
cell: 619-787-5767
email:  dpalella@gmail.com
http://www.linkedin.com/in/davidpalella

web site:  http://www.BSVpartners.com

blog: http://biobizdev.blogspot.com


& Group Founder:

Infectious Disease R&D and Business Network
http://www.linkedin.com/e/-ubgx8c-godydbie-43/vgh/3937807/

Japan Biotech / Biopharma Partnering Forum
http://www.linkedin.com/e/vgh/2857975/

Biotech / Pharma Business Development, Licensing & Dealmaking
http://www.linkedin.com/e/-ubgx8c-gp40f4dt-22/vgh/3964633/

& Co-founder:

Stem Cells & Regenerative Medicine
http://www.linkedin.com/e/vgh/3921448

------